Markets: Eerie calm

Markets: Eerie calm

it is not clear when market sentiment can change; as in the past, it can be quite sudden.
At a turn and yet not

At a turn and yet not

RBI could be tempted to cut policy rate to support growth at its bi-monthly review.

South African geranium root may kill HIV-1

Jan 31 2014, 14:55 IST
Comments 0
PS extracts block attachment of virus particles to host cells and thus effectively prevent the virus from invading cells.Reuters PS extracts block attachment of virus particles to host cells and thus effectively prevent the virus from invading cells.Reuters
SummaryThese extracts represent a potential new class of anti-HIV-1 agents for the treatment of AIDS.

Extracts of the South African geranium plant can inactivate the most widespread type of HIV and prevent the deadly virus from invading human cells, according to a new study.

Scientists from the Helmholtz Zentrum Munchen, Germany have found that these extracts represent a potential new class of anti-HIV-1 agents for the treatment of AIDS.

Researchers demonstrate that root extracts of the medicinal plant Pelargonium sidoides (PS) contain compounds that attack HIV-1 particles and prevent virus replication.

A team spearheaded by Dr Markus Helfer and Professor Ruth Brack-Werner performed a detailed investigation of the effects of PS extracts on HIV-1 infection of cultured cells.

They demonstrated that PS extracts protect blood and immune cells from infection by HIV-1, the most widespread type of HIV.

PS extracts block attachment of virus particles to host cells and thus effectively prevent the virus from invading cells.

Chemical analyses revealed that the antiviral effect of the PS extracts is mediated by polyphenols. Polyphenol mixtures isolated from PS extracts retain high anti-HIV-1 activity but are even less toxic for cells than the crude extract.

Safety of PS-extracts has been established in several clinical trials, researchers said.

"PS-extracts are a very promising lead for the development of the first scientifically validated phytomedicine against HIV-1. PS extracts attack HIV-1 with a mode-of-action that is different from all anti-HIV-1 drugs in clinical use," research group leader Brack-Werner said.

"Therefore a PS-based phytomedicine may be a valuable supplement for established anti-HIV therapies. Furthermore, PS extracts are attractive candidates for increasing anti-HIV-1 therapy options in resource-limited settings, since they are easy to produce and do not require refrigeration.

"The results of our study and the proven safety of PS extracts encourages their testing in HIV-1 infected individuals as next step," said Brack-Werner.

According to the World Health Organisation (WHO), more than 35 million people in the world are infected with HIV, the majority with HIV-1, researchers said.

Without treatment, HIV destroys the immune system and causes the acquired immunodeficiency syndrome (AIDS), which is a life-threatening disease. HIV/AIDS is one of the 10 leading causes of death worldwide, they said.

The study was published in the journal PLOS ONE.

Ads by Google

More from Health

Reader´s Comments
| Post a Comment
Please Wait while comments are loading...